I. Koier

SDZ PSC 833 in combination with doxorubicin: a phase I and pharmacologic study in solid tumors

G. Giaccone, S. Linn, H. Pinedo, 1994 .

Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor.

H. Hansen, J. Verweij, H. Rosing, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agents.

O. Dalesio, M. van Glabbeke, J. Wanders, 1991, European journal of cancer.

Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute.

S. Rodenhuis, O. Dalesio, A. V. van Oosterom, 1992, Seminars in oncology.

Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09.

J. Verweij, J. Schellens, W. Loos, 1994, Journal of the National Cancer Institute.

Phase I and pharmacokinetic study of rhizoxin.

D. Bissett, S. Kaye, J. Cassidy, 1992, Cancer research.

Phase I and pharmacokinetic study of a novel mitomycin C analog KW‐2149

L. Dirix, C. Ardiet, A. Oosterom, 1995, Anti-cancer drugs.

Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion.

S. Rodenhuis, H. Rosing, J. Beijnen, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG)

S. Aamdal, J. Wanders, J. Verweij, 2000, Cancer Chemotherapy and Pharmacology.

Clinical studies with EO9, a new indoloquinone bioreductive alkylating cytotoxic agent. EORTC Early Clinical Trials Group.

S. Aamdal, J. Verweij, J. Schellens, 1994, Oncology research.

A phase I and pharmacokinetic trial of KW-2149, a mitomycin C analogue, in patients with solid tumours

L. Dirix, C. Ardiet, A. Oosterom, 1993 .